Benzodiazepine Drugs for the treatment of anxiety is projected to account for over 53% share in the market by 2026
The U.S. is expected to account for around one-third of the total share in the global benzodiazepine drugs market by 2026. Growing prevalence of anxiety in parallel with rising awareness regarding benzodiazepine drugs is reflecting on increasing opportunities for players in the U.S. market. As per a report by the Anxiety and Depression Association of America (ADAA), each year, over 40 Mn adults in the U.S. suffer from anxiety disorders.Presence of a large number of hospital and retail pharmacies further makes it easy for individuals to purchase benzodiazepine drugs. A significant influence of high concentration of leading players is also auguring well for the U.S. benzodiazepine drugs market, which has been discussed in detail, in a recent Fact.MR study.
Request a report sample to gain comprehensive market insights at https://www.factmr.com/connectus/sample?flag=S&rep_id=4432
Key Highlights of Benzodiazepine Drugs Market Study
• Easy accessibility is a key feature driving substantial sales of benzodiazepine drugs through retail pharmacies. By 2026, these pharmacies are projected to record value tantamount to US$ 1.4 Bn. Additionally, sales prospects for benzodiazepine drugs are likely to grow during the forecast period, as consumers are evincing high interest in online pharmacies.
• Popularity of short-acting benzodiazepine drugs is expected to increase during the forecast period, as these induce less hangover effect and take relatively short time of action. On the back of this, around 77% of the total share would be attributable to the sales of short-acting benzodiazepine drugs.
• Being a highly prevalent disorder among individuals leading a demanding lifestyle, anxiety is projected to account for a sizeable share tantamount to around 53% in the benzodiazepine drugs market during the forecast period.
• Reduction in the number of prescriptions for benzodiazepine drugs, especially in countries such as the U.S., the U.K., and Canada, would impede market growth during the forecast period.
For information on the Research Approach used in the Report, Request Methodology@ https://www.factmr.com/connectus/sample?flag=RM&rep_id=4432
A subject matter expert at Fact.MR opines, “Regulations regarding development of benzodiazepine drugs are relatively stringent in developed regions such as North America and Europe, which opens ground for branded as well as generic drugs in developing regions. As a result, entry barriers in developed regions would be high, while those in developing regions would be moderate.”
High Popularity of Generic Drugs Puts Pressure on Branded Products of Leading Players
The benzodiazepine drugs market features fragmentation, as leading players operate under the constant pressure of patent expiration of branded products. High investments made towards the development of innovative and new products by leading players intensifies pressure to achieve the desired RoI. For instance, in 2017, F.Hoffmann-La Roche AG invested around one-fifth of the total revenue to strengthen the pipeline of innovative products. Stringent regulations on innovative drugs further make it difficult for leading players to gain desired marketability.
On the other side, the focus of prominent and leading players is on achieving better penetration into the benzodiazepine drugs market through the development of generic drugs. Growing sales of generic benzodiazepine drugs is putting pressure on leading players to squeeze their profit margins and adopt a cost-competitive strategy to have better sales prospects.
Get Full Access of the Report @ https://www.factmr.com/checkout/4432/S
Find More Valuable Insights on Benzodiazepine Drugs Market
Fact.MR, in its new offering, brings to the fore an unbiased analysis of the global benzodiazepine drugs market, presenting historical demand data (2016-2019), and forecast statistics for the period of 2020-2026. The study divulges compelling insights on the benzodiazepine drugs market on the basis of distribution channel (hospital pharmacies, retail pharmacies, and others), time of action (ultra-short acting, short acting, and long acting), application (anxiety, seizures, insomnia, alcohol withdrawal, and others), and product (alprazolam, clonazepam, diazepam, lorazepam, and others), across five major regions.
About the Healthcare Division at Fact.MR
The healthcare team at Fact.MR assists clients with unique business intelligence needs on a global level. With a repertoire of over 1,000 reports and 1 million+ data points, the team has analysed the healthcare industry to a micro-level across 50+ countries for over a decade. The team provides end-to-end research and consulting services to help keep clients at the top of the game.
Unit No: AU-01-H
Gold Tower (AU)
Plot No: JLT-PH1-I3A
Jumeirah Lakes Towers, Dubai
United Arab Emirates
Contact: +353-1-6111-593
E-mail: sales@factmr.com
Website : https://www.factmr.com
About Fact.MR
Fact.MR is a fast-growing market research firm that offers the most comprehensive suite of syndicated and customized market research reports.
We believe transformative intelligence can educate and inspire businesses to make smarter decisions.
We know the limitations of the one-size-fits-all approach; that’s why we publish multi-industry global, regional, and country-specific research reports.
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Benzodiazepine Drugs for the treatment of anxiety is projected to account for over 53% share in the market by 2026 here
News-ID: 2233675 • Views: …
More Releases from Fact.MR
Allyl Polyether Market Expected to Grow at 4.5% CAGR to US$ 99.1 Million by 2033
The global Allyl Polyether Market (アリルポリエーテル市場) was valued at approximately US$ 63.8 million in 2023 and is projected to reach around US$ 99.1 million by the end of 2033, growing at a compound annual growth rate (CAGR) of 4.5%.
The Allyl Polyether Market is a segment of the polymer industry that has been witnessing steady growth in recent years. This growth can be attributed to several factors, including the increasing demand…
Construction Aggregate Market to Surge at 6.5% CAGR Through 2034
The global Construction Aggregate Market (建設骨材市場) is poised to reach US$ 418.14 billion by 2024, with a projected Compound Annual Growth Rate (CAGR) of 6.5% from 2024 to 2034. The surge in global population has fueled construction activities, leading to a substantial demand for construction aggregates. Moreover, governments in developing nations are heavily investing in infrastructure development, further boosting the demand for construction aggregates. The launch of numerous mega projects…
Chromatography Syringes Market to Experience Notable Growth by 2032
The market research and competitive intelligence company Fact.MR recently released a report estimating that sales of Chromatography Syringes would reach a valuation of US$ 140 million by 2032, growing at a compound annual growth rate (CAGR) of roughly 6% between 2022 and 2032.
Developments in chromatography syringe design and calibration, such as digitalization leading to appropriate sample pooling, are improving the performance of chromatography columns. These advancements offer benefits such faster…
Sacroiliac Joint Fusion Market: An Overview of the Forecasted CAGR of 20.2% from …
It is projected that the worldwide market for Sacroiliac Joint Fusion would be valued US$ 3,900 million by 2032, up from US$ 620 million in 2022. The market is anticipated to expand at a CAGR of 20.2% between 2022 and 2032. the rapid technological advancement in the healthcare industry and the growing demand for minimally invasive surgical treatments are responsible for the market's progress. orthopedic doctors at Yale Medicine frequently…
More Releases for Drugs
Global Antithrombotic Drugs Market | Global Antithrombotic Drugs Industry | Glob …
Antithrombotic drugs are special drugs that help to prevent the formation of thrombus or clot. These drugs are used to reduce the formation of blood clots by reducing the capability of body to form a blood clot. Antithrombotic drugs act by preventing the production of vitamin K in the liver. Anticoagulant, antiplatelet, and thrombolytic agents are different types of antithrombotic agents that act by different clotting processes. Arterial & venous…
Global HIV Drugs Market | Global HIV Drugs Industry | Global HIV Drugs Market Re …
Human immunodeficiency Virus (HIV) could be a chronic and severe sickness which might be transferred from one person to a different through blood-to-blood and sexual contact. it's a deadly disease that attacks immune cells called CD-4 cells, creating body vulnerable to infections and alternative diseases. Over the years, the rising prevalence of HIV sickness worldwide has completely influenced the demand for HIV medicine. HIV medicine facilitate in preventing the multiplication…
Hepatitis Drugs Market by Therapeutics, Diagnostics, Patient, Drugs Policy
The global hepatitis drugs market is growing due to increasing incidences of hepatitis and increasing support from government organizations. In addition, the growing geriatric population, and increasing R&D investments on hepatitis research and drug discovery are also driving the growth of the global hepatitis drugs market.
Access Detailed Report Summary: https://www.psmarketresearch.com/market-analysis/hepatitis-drugs-market
Among the various types, the hepatitis C segment is expected to be the largest segment, and expected to witness the fastest…
Epilepsy Drugs Market by Country, Drugs, Company & Forecast
For More Information:
https://renub-research.blogspot.com/2019/04/the-factors-that-are-driving-global.html
Epilepsy is a chronic disease in which patient’s brain activities become abnormal due to seizures. Seizure is an unexpected rush of electrical activity in the brain. Seizure is categorized by two types - generalized seizures and focal or partial seizures. Generalized seizures affect the whole brain whereas focal or partial seizures affect just one part of the brain. Global epilepsy drugs market is expected to cross US$…
Prospect of Global Excipients Market Research Report 2017 with Application inclu …
ResearchMoz added Latest Research Report titled " Global Excipients Market Research Report 2017 " to it's Large Report database.
In this report, the global Excipients market is valued at USD XX million in 2016 and is expected to reach USD XX million by the end of 2022, growing at a CAGR of XX% between 2016 and 2022.
Geographically, this report is segmented into several key Regions, with production, consumption, revenue (million USD),…
Drugs research: Misuse by shareholders of the drugs industry
A new textbook illustrates the complex and multi-faceted dimensions of evidence building in European drugs research. On one level, the authors have identified practical and philosophical challenges regarding knowledge production including, for example, measurements of the drugs problem; researching the online world; and interpreting on-site drug tests.
On another level, the authors have highlighted challenges regarding knowledge production such as the misuse of evidence by knowledge brokers and policymakers.…